Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ribosomal protein stoichiometry and ribosome-interactome changes during cardiac hypertrophy

ABSTRACT: TRAP was performed using ribo-tag heart tissues 4 weeks after Sham or TAC surgery. The products of TRAP were sent for label-free mass spectrometry.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart

SUBMITTER: yazhi peng

LAB HEAD: ZhanPeng Huang

PROVIDER: PXD067222 | Pride | 2026-07-27

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Ribo-Tag_ShamHA_replicates_1.zip	Other
	Ribo-Tag_ShamHA_replicates_2.zip	Other
	Ribo-Tag_ShamHA_replicates_3.zip	Other
	Ribo-Tag_ShamHA_replicates_4.zip	Other
	Ribo-Tag_Sham_replicates_1.zip	Other

Items per page:

1 - 5 of 18

Similar Datasets

CDK5RAP3 overexpression regulates proteome of hypertrophic heart

Project description:Heart tissues were collected from mice injected with AAV9-Cdk5rap3 or AAV9-Ctrl 4 weeks after Sham or TAC surgery, and sent for label-free mass spectrometry.

2026-07-27 | PXD067140 | Pride

CDK5RAP3 knock-down regulates proteome in HL-1 cells

Project description:HL-1 cells were harvested 48 hours after si-Cdk5rap3 or si-NC transfection. Protein lysates were sent for label-free mass spectrometry.

2026-07-27 | PXD067221 | Pride

miRNA atlas of hypertrophy progression in a murine TAC model of experimental Hypertrophy

Project description:miRNA pattern of cardic myocytes, cardiac fibroblasts and cardiac endothelial cells isolated from adult mice hearts at different time points after transaortic constriction (TAC) or sham surgery.

2020-07-01 | GSE66974 | GEO

FoxO1 Binding in Cardiac Hypertrophy

Project description:Anti-FoxO1 chromatin immunoprecipitation-high throughput sequencing (ChIP-Seq) was performed on mouse heart tissue following 7 days vehicle treatment/sham-operation, isoproterenol injection (subcutaneous, 3mg/kg/day), or transverse aortic constriction (TAC). Pool of 3 hearts per condition.

2020-07-08 | GSE144011 | GEO

Expression data of murine model of cardiac hypertrophy

Project description:An initial cellular change in the pathogenesis of heart failure is cardiomyocyte hypertrophy, characterized by increased cell size, enhanced protein synthesis and reactivation of fetal genes. In addition to mechanical stresses, several neurohumoral factors have been identified as potent hypertrophic agents, including angiotensin II, endothelin, and catecholamines. We used microarrays to study the gene expression during cardiac hypertrophy. Balb/c mice (6-8w) were treated with TAC, ATII infusion, and myocardial infarction. TAC model: The transverse aorta (TAC) was constricted at the upper left sternal border by ligation with a 7-silk surgical thread and 27-gauge needle, which was removed thereafter. Sham-operated controls underwent an identical procedure without TAC. At 1 week and 1month after the procedure, LV was harvested. Ang II model.: Ang II was dissolved in 0.9% NaCl at concentrations sufficient to allow an infusion rate of 2.0 mg/kg/day, known to produce hypertension and cardiac hypertrophy. Control mice received a vehicle (saline) via an osmotic minipump. At 1 week after the procedure, LV was harvested. MI model: The proximal portion of the left coronary artery was ligated using an 8-0 nylon thread. Myocardial ischemia was confirmed by the discoloration of the heart and typical ECG changes. After 30 min occlusion, the left coronary artery was reperfused by loosening the ligature. In sham-operated mice (SHAM), the pericardium was opened, but the coronary artery was not ligated. At 1 day, 1week, and 1 month after the procedure, LV was harvested.

2011-12-31 | E-GEOD-26671 | biostudies-arrayexpress

Combined miRNA and mRNA Sequencing Identifies Protective Transcriptional Signature of Enhanced PI3Kalpha Signaling in Cardiac Hypertrophy

Project description:A molecular and bioinformatic pipeline permitting comprehensive analysis and quantification of myocardial miRNA and mRNA expression with next-generation sequencing was developed and the impact of enhanced PI3Kalpha signaling on the myocardial transcriptome signature of pressure overload-induced pathological hypertrophy was explored. miRNA and mRNA-Seq were carried out in four groups of mouse LV samples: WT sham, WT+TAC, caPI3Kalpha sham, caPI3Kalpha+TAC

2013-05-01 | E-GEOD-35350 | biostudies-arrayexpress

PGK1 drives pathological cardiac hypertrophy and remodeling by inducing cardiomyocyte ferroptosis through the vimentin/PI3K/Akt pathway

Project description:Proteomic analysis of TAC model mice with myocardial hypertrophy and the sham operation group mice.

| PXD065602 |

Transcriptome analysis of cardiac hypertrophy

Project description:RNA sequencing (RNA-seq) on polyadenylated transcripts extracted from cardiomyocytes isolated from mice after 1 week of transverse aortic constriction (TAC) and in control mice (sham). 2-month-old male C57BL/6J mice were subjected under anesthesia to transverse aortic constriction for 1 week, then we performed RNA-seq on isolated cardiomyocytes

2013-11-30 | E-MTAB-1507 | biostudies-arrayexpress

Transcriptome profiling of pathological cardiac hypertrophy

Project description:Here, we performed pathological cardiac hypertrophy transcriptome analyses by using heart tissue from Sham or TAC surgery to identify the charecteric in pathological cardiac hypertrophy. In addition, through combined analysis with the aging-associated transcriptome to identify the similarity and difference between heart ageing and pathological cardiac hypertrophy.

2025-01-29 | GSE203083 | GEO

Genome-wide mapping of histone H3 modifications in cardiac hypertrophy

Project description:ChIP-Sequencing using antibody to H3K9ac,H3K27ac,H3K4me3, H3K79me2, H3K9me2, H3K9me3 and H3K27me3 in cardiomyocytes isolated from mice after 1 week of transverse aortic constriction (TAC) and in control mice (sham).

2013-11-30 | E-MTAB-1506 | biostudies-arrayexpress